Can a Mother Donate Platelets for a Baby With FNAIT?
At a Glance
Mothers and fathers generally cannot donate platelets directly to a baby with FNAIT. Maternal blood contains the harmful antibodies and requires hours of processing, while paternal platelets would be immediately destroyed. Doctors rely on safer, pre-screened donor platelets for emergency treatment.
It is completely natural to want to donate your own blood or platelets to help your baby. However, in modern NICU emergencies, parents are rarely able to act as direct donors for Fetal and Neonatal Alloimmune Thrombocytopenia (FNAIT). Relying on carefully screened donor platelets from a blood bank is almost always a faster, safer option.
Additionally, blood banks strictly restrict women from donating blood or platelets in the weeks immediately following childbirth. This rule exists to protect your own physical recovery. But even if an exception were made, using a mother’s platelets involves complicated medical risks.
Why Maternal Platelets Are Complicated
In FNAIT, the mother’s immune system creates antibodies that cross the placenta and mistakenly attack the baby’s platelets [1][2]. Because these are your antibodies, they do not attack your own platelets. This means your platelets themselves are technically a perfect match for your baby.
However, when you donate blood or platelets, the collection includes plasma—the liquid part of the blood. Your plasma contains the very antibodies that are causing your baby’s platelets to drop [3]. If your platelets were given to your baby straight from your body, it would introduce more of these harmful antibodies into their system, worsening the condition.
The “Washing” Process
To safely use a mother’s platelets, the blood must undergo a rigorous laboratory process called washing. This involves separating the platelets and thoroughly washing away the mother’s plasma so no harmful antibodies remain. Furthermore, any blood products donated by a first-degree relative must be irradiated with a specific dose of radiation. This step prevents a rare but fatal complication where the donor’s immune cells attack the baby’s tissues.
Both washing and irradiating take hours [4]. In a NICU, a baby with severely low platelets needs immediate treatment to prevent dangerous bleeding, such as an intracranial hemorrhage (brain bleed). The hours required to prepare maternal platelets are hours your baby cannot afford to wait.
Why Can’t the Father Donate?
If a mother’s plasma is the problem, it is logical to wonder if the father could donate instead. Unfortunately, the father is the least compatible donor. In FNAIT, the baby’s platelets are being attacked because they inherited a specific trait from the father that the mother’s immune system does not recognize. If you give the father’s platelets to the baby, the mother’s antibodies (which are still circulating in the baby’s blood) will immediately recognize and destroy them too.
Faster, Safer Alternatives
Because time is critical, neonatologists rely on high-quality donor platelets that are already processed and ready for emergencies [5].
- Pre-screened HPA-matched platelets: Platelets have their own version of a “blood type,” called Human Platelet Antigens (HPA). Blood banks often have donors whose platelets naturally lack the specific target (like HPA-1a) that your antibodies attack. These are the ideal choice [6].
- Random donor platelets: If matched platelets are not immediately available, doctors will use “random donor” platelets [6]. While “random” might sound concerning, these are heavily screened, standard-of-care medical treatments. Although the antibodies in your baby’s blood might eventually destroy these platelets too, they successfully boost the baby’s platelet count and stop bleeding in the critical short term, buying time while matched platelets arrive.
Your baby may also receive Intravenous Immunoglobulin (IVIG) alongside transfusions, which helps stop the baby’s body from destroying platelets so quickly.
It can be incredibly difficult to hear that you cannot directly give your baby what they need. However, by using standard donor platelets, the medical team can provide immediate, life-saving care without dangerous delays.
Common questions in this guide
Can a mother donate platelets for her baby with FNAIT?
Why can't the father donate platelets for a baby with FNAIT?
How are maternal platelets made safe for a baby with FNAIT?
What type of donor platelets are given to babies with FNAIT?
What is IVIG used for in treating FNAIT?
Questions to Ask Your Doctor
Curated prompts to bring to your next appointment.
- 1.What is my baby's current platelet count, and are they showing any clinical signs of bleeding?
- 2.Are HPA-matched platelets currently available in the hospital's blood bank, or do they need to be ordered from a regional supplier?
- 3.What is the expected timeline for receiving the matched donor platelets?
- 4.Will my baby be receiving IVIG alongside the platelet transfusions to help stabilize their count?
- 5.How frequently will my baby's platelet counts be monitored after the transfusion?
Questions For You
Tap a prompt to share your answer — we'll use it plus this page's context to start a tailored conversation.
Related questions
References
References (6)
- 1
Alloantibody against new platelet alloantigen (Lap(a)) on glycoprotein IIb is responsible for a case of fetal and neonatal alloimmune thrombocytopenia.
Wihadmadyatami H, Heidinger K, Röder L, et al.
Transfusion 2015; (55(12)):2920-9 doi:10.1111/trf.13238.
PMID: 26388194 - 2
Low-dose prednisone and immunoglobulin G treatment for woman at risk for neonatal alloimmune thrombocytopenia and T helper 1 immunity.
Skariah A, Sung N, Salazar Garcia MD, et al.
American journal of reproductive immunology (New York, N.Y. : 1989) 2017; (77(6)) doi:10.1111/aji.12649.
PMID: 28240400 - 3
Successful management of a pregnant woman with severe ANKRD26-related thrombocytopenia and anti-HPA-5b alloimmunization.
Lazaro E, Houssin C, Sentilhes L, et al.
Platelets 2020; (31(6)):827-829 doi:10.1080/09537104.2019.1678116.
PMID: 31607198 - 4
Assessment of platelet indices, beta-thromboglobulin and platelet factor IV in platelet concentrate at University of Ilorin Teaching Hospital, Nigeria.
Olatunbosun LO, Muhibi MA, Oke OT, et al.
Scientific reports 2025; (15(1)):42155 doi:10.1038/s41598-025-26247-y.
PMID: 41298645 - 5
Neonatal alloimmune thrombocytopaenia associated with maternal HLA antibodies.
Wendel K, Akkök ÇA, Kutzsche S
BMJ case reports 2017; (2017()) doi:10.1136/bcr-2016-218269.
PMID: 28679510 - 6
Fetal and neonatal alloimmune thrombocytopenia: recommendations for evidence-based practice, an international approach.
Lieberman L, Greinacher A, Murphy MF, et al.
British journal of haematology 2019; (185(3)):549-562 doi:10.1111/bjh.15813.
PMID: 30828796
This page explains blood donation considerations for FNAIT for educational purposes only. Always consult your neonatologist or hematologist for specific transfusion decisions for your baby.
Get notified when new evidence is published on Fetal and neonatal alloimmune thrombocytopenia.
We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.